China Business Intelligence Network News: Recently, the State Food and Drug Administration issued an announcement on the approval and registration of 163 medical device products, including 110 domestic third-class medical device products, 28 imported third-class medical device products, and imported second-class medical devices. 23 equipment products, 2 Hong Kong, Macao and Taiwan medical equipment products.

According to statistics, from January to June 2021, the State Food and Drug Administration approved and registered a total of 736 medical devices, including 100 orthopedic products, 35 spinal products, 19 trauma products, 18 joint products, and 24 sports products. Medical products and 4 other categories of products.

Data source: compiled by the State Food and Drug Administration and China Commercial Industry Research Institute

As we age, the prevalence of orthopedic diseases such as fractures, scoliosis, spondylopathies, and arthritis will become higher and higher, and the base of orthopedic patients will gradually increase. In addition, the number of sports people in my country is increasing year by year. It is estimated that by 2025, the domestic sports population will reach 500 million. The subsequent increase in the incidence of sports injury diseases, and the demand for orthopedic treatment will continue to grow. It is estimated that the compound annual growth rate of the domestic orthopedics equipment market is about 15%, which shows that orthopedics will be a high-growth and high-increment market in the future.

Data show that the sales revenue of my country's orthopedic implantable medical device market has increased from 19.1 billion yuan in 2016 to 30.8 billion yuan in 2019, with a compound growth rate of 17.3%. It is estimated that by 2021, the national orthopedic implantable medical device market will reach 39.5 billion yuan.

Data source: collated by Guangzhou Piaodian Medical Information Co., Ltd. and China Commercial Industry Research Institute

In terms of composition, unlike joint products occupying the largest market share of the global orthopedic implantable device market, the largest category of orthopedic implantable medical device market in my country is trauma, with a market share of 29.80%. This market characteristic is mainly caused by the undeveloped and mature orthopedic implant market in my country. As the consumption power of Chinese residents increases and the acceptance of high-end orthopedic implant products increases, the market share of spine and joints in my country will continue to increase.

Data source: collated by Guangzhou Piaodian Medical Information Co., Ltd. and China Commercial Industry Research Institute

As the coverage of orthopedic centralized sourcing products continues to expand, more products will fall sharply, and more companies will usher in life and death. Successful bidders will exchange price for volume, unsuccessful companies will face the risk of being eliminated and the industry will face a reshuffle. At the same time, centralized procurement also brings more development opportunities to enterprises with strong innovation capabilities, and will enter the fast lane of development under the promotion of policies in the future. Big Data Analysis of Orthopedics Implantable Medical Devices